Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 93INDUSTRY 33NIH 6NETWORK 3FED 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Prostatic Diseases 1Neoplasm Metastasis 1

Interventions

Cisplatin 118Radiotherapy 114Cyclophosphamide 93Paclitaxel 84Gemcitabine 74Carboplatin 67Filgrastim 60Doxorubicin 57Vincristine 56Etoposide 56Docetaxel 56Fluorouracil 51Cytarabine 41Prednisone 40Methotrexate 40Leucovorin 39Dexamethasone 37Capecitabine 36Irinotecan 35Rituximab 29Oxaliplatin 28Granulocyte Colony-Stimulating Factor 27Cetuximab 26Bevacizumab 26durvalumab 24Temozolomide 24Radiotherapy, Intensity-Modulated 24Peripheral Blood Stem Cell Transplantation 24Magnetic Resonance Spectroscopy 24Surgical Procedures, Operative 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × enzalutamide × Clear all
NCT02225704 2026-04-13

Radium-223 in Combination With Enzalutamide

Cancer Trials Ireland

Phase 2 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT03869762 2026-04-13

DICE

Cancer Trials Ireland

Phase 2 Terminated
7 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06582628 2024-12-02

TEAM PC

Fundacion Oncosur

Phase 2 Recruiting
78 enrolled
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡